Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_assertion type Assertion NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_head.
- NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_provenance.
- NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_assertion evidence source_evidence_literature NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_provenance.
- NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_assertion SIO_000772 8501986 NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_provenance.
- NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_assertion wasDerivedFrom befree-20150227 NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_provenance.
- NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_assertion wasGeneratedBy ECO_0000203 NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_provenance.